Replicative senescence in patients with chronic kidney failure

被引:0
|
作者
Jimenez, R [1 ]
Carracedo, J [1 ]
Santamaría, R [1 ]
Soriano, S [1 ]
Madueño, JA [1 ]
Ramírez, R [1 ]
Rodríguez, M [1 ]
Martín-Malo, A [1 ]
Aljama, P [1 ]
机构
[1] Hosp Univ Reina Sofia, Serv Nefrol, Unidad Invest, Cordoba 14004, Spain
关键词
cellular senescence; chronic kidney disease; inflammation;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Chronic activation of immunocompetent cells may lead to stress-induced premature senescence (SIPS); these senescent cells are characterized by a decrease in telomere length. The present study evaluates SIPS in circulating immunocompetent cells from predialysis patients, patients on hemodialysis, and in renal transplant patients with normal renal function. Methods. Determination of telomere length by flow-fluorescence in situ hybridization (FISH), expression of surface molecules, and evaluation of apoptosis was performed by flow cytometry. Results. In uremic predialysis patients, we observed a subpopulation of lymphocytes with short telomeres. However, in this population of patients we did not observe SIPS mononuclear cells. In hemodialysis patients, we found a subpopulation of SIPS mononuclear cells that also showed phenotypic changes of proinflammatory activity. Finally, transplant patients with normal renal function also exhibited a subpopulation of SIPS lymphocytes, which can be attributed to chronic lymphocyte activation induced by the major histocompatibility complex. Conclusion. In chronic kidney disease patients, immunocompetent cells undergo SIPS, a process associated with chronic cell activation and induced by numerous stimuli including uremia, hemodialysis membranes, and bacterial products. Because SIPS immunocompetent cells are activated cells with proinflammatory features and live longer in peripheral blood, it is likely that SIPS cells contribute significantly to the chronic inflammatory state of patients with advanced renal failure.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 50 条
  • [31] Prevention of Heart Failure in Patients with Chronic Kidney Disease
    Raghban A.
    Kirsop J.
    Tang W.H.W.
    Current Cardiovascular Risk Reports, 2015, 9 (1) : 1 - 11
  • [32] OPTIMAL MANAGEMENT OF CHRONIC HEART FAILURE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Zachariah, Donah
    Kaira, Philip A.
    Kaira, Paul R.
    JOURNAL OF RENAL CARE, 2009, 35 (01) : 2 - 10
  • [33] CHRONIC KIDNEY DISEASE IN THE EVALUATION OF COMORBIDITY IN PATIENTS WITH CHRONIC HEART FAILURE
    Efremova, E.
    Shutov, A.
    ATHEROSCLEROSIS, 2020, 315 : E263 - E264
  • [34] Xanthine metabolism in chronic heart failure patients with chronic kidney disease
    Smolianyk, K. Kateryna
    Bilchenko, A.
    Kolomiiets, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 138 - 138
  • [35] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Mari Katsumata
    Nobuhito Hirawa
    Koichiro Sumida
    Minako Kagimoto
    Yosuke Ehara
    Yuki Okuyama
    Megumi Fujita
    Akira Fujiwara
    Mayumi Kobayashi
    Yusuke Kobayashi
    Yuichiro Yamamoto
    Sanae Saka
    Keisuke Yatsu
    Tetsuya Fujikawa
    Yoshiyuki Toya
    Gen Yasuda
    Kouichi Tamura
    Satoshi Umemura
    Clinical and Experimental Nephrology, 2017, 21 : 858 - 865
  • [36] Chronic heart failure risk factors in patients with chronic kidney pathology
    Ilyicheva, O. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2008, 7 (01): : 63 - 68
  • [37] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Katsumata, Mari
    Hirawa, Nobuhito
    Sumida, Koichiro
    Kagimoto, Minako
    Ehara, Yosuke
    Okuyama, Yuki
    Fujita, Megumi
    Fujiwara, Akira
    Kobayashi, Mayumi
    Kobayashi, Yusuke
    Yamamoto, Yuichiro
    Saka, Sanae
    Yatsu, Keisuke
    Fujikawa, Tetsuya
    Toya, Yoshiyuki
    Yasuda, Gen
    Tamura, Kouichi
    Umemura, Satoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 858 - 865
  • [38] Reversibility of chronic heart failure symptoms in chronic kidney disease patients
    Belov, V. V.
    Ilyicheva, O. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (01): : 68 - 72
  • [39] CHRONIC KIDNEY FAILURE
    MEYERLEHNERT, H
    INTERNIST, 1992, 33 (10): : W99 - W111
  • [40] Chronic Kidney Failure
    Tanriverdi, Mehmet Halis
    Karadag, Aytac
    Hatipoglu, Esra Suheda
    KONURALP TIP DERGISI, 2010, 2 (02): : 27 - 32